Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identifying prostate carcinoma by MALDI-Imaging.

Kristina Schwamborn1, René C Krieg, Marcus Reska

  • 1Institute of Pathology, RWTH Aachen University, 52074 Aachen, Germany.

International Journal of Molecular Medicine
|July 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of [<sup>18</sup>F]Flotufolastat PET Using Visual RECIP in Docetaxel-Treated Metastatic Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

HistoGWAS: an AI-enabled framework for automated genetic analysis of tissue phenotypes in histology cohorts.

Genome biology·2026
Same author

Radiation Therapy Combined with Immunotherapy Before Radical Cystectomy in Locally Advanced Bladder Cancer: A Prospective, Single-arm, Multicenter, Phase 2 Trial (RACE-IT).

European urology oncology·2026
Same author

Spatial Proteomics of the Normal Breast Collagen Stroma: Links to Density and Body Mass Index.

Journal of proteome research·2026
Same author

Cohort-Scale Spatial Autocorrelation for Tumor Prediction in Mid-Infrared Pathology and Spatial Biomarker Discovery Using MALDI Imaging Lipidomics.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 <sup>68</sup>Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management.

European journal of nuclear medicine and molecular imaging·2025

Matrix-assisted laser desorption/ionization (MALDI)-Imaging shows promise for prostate cancer research. This technique identified distinct protein patterns in cancerous versus non-cancerous prostate tissue, aiding biomarker discovery.

Area of Science:

  • Oncology
  • Proteomics
  • Biomarker Discovery

Background:

  • Prostate cancer is a leading global malignancy.
  • Current diagnosis relies partly on prostate-specific antigen (PSA) testing, which lacks specificity.
  • Identifying novel biomarkers is crucial for accurate disease staging and understanding pathogenesis.

Purpose of the Study:

  • To evaluate Matrix-assisted laser desorption/ionization (MALDI)-Imaging for analyzing protein expression in prostate cancer.
  • To identify potential protein biomarkers differentiating cancerous from normal prostate tissue.
  • To assess the diagnostic potential of MALDI-Imaging in prostate cancer.

Main Methods:

  • Analysis of 22 prostate tissue sections (11 cancerous, 11 non-cancerous) using MALDI-Imaging.

Related Experiment Videos

  • Acquisition of mass spectrometric data to map protein expression spatially.
  • Application of a support vector machine algorithm for classification of tissue regions.

    • Main Results:

    • Distinct protein expression profiles were observed between normal and cancerous prostate tissues.
    • The support vector machine algorithm achieved 88% cross-validation accuracy, with 85.21% sensitivity and 90.74% specificity.
    • Four specific protein peaks were identified as differentially overexpressed: 2,753 Da and 6,704 Da in non-cancerous glands, and 4,964 Da and 5,002 Da in cancerous glands.

    Conclusions:

    • MALDI-Imaging is a powerful tool for identifying potential prostate cancer biomarkers.
    • This technique can visualize spatial protein distribution and correlate it with histopathology.
    • The findings highlight MALDI-Imaging's potential to advance prostate cancer diagnostics and elucidate its pathogenesis.